Ablation of paroxysmal and persistent atrial fibrillation in the very elderly real-world data on safety and efficacy.
Kevin WillyKristina WasmerDirk G DecheringJulia KöbePhilipp S LangeNils BögeholzChristian EllermannFlorian ReinkeGerrit FrommeyerLars EckardtPublished in: Clinical cardiology (2020)
PVI for AF is a feasible treatment option also in patients >75 years with a reasonable success and safety profile. Higher success rates occurred in patients treated with a single-shot device as compared to point-by-point ablation.
Keyphrases
- atrial fibrillation
- catheter ablation
- end stage renal disease
- left atrial
- ejection fraction
- newly diagnosed
- chronic kidney disease
- oral anticoagulants
- left atrial appendage
- heart failure
- direct oral anticoagulants
- prognostic factors
- peritoneal dialysis
- percutaneous coronary intervention
- coronary artery disease
- big data
- combination therapy
- machine learning
- middle aged
- mitral valve
- deep learning
- data analysis
- replacement therapy